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Chemical Basis for Pulegone Mediated Hepatotoxicity: 
a) Role of Stereo- and Regioselectivity b) Contribution of Piperitenone c) A New Route 
for Fonnation of p-Cresol d) A Key Step in the Biogenews of Lower Furanoterpenoids 
R-(+)-pulegone, a monoterpene ketone, is one of the major constituents of 
pennyroyal 011 from mentha puleglum. It has been widely used as fragrance component, a 
flavormg agent and also as an herbal medicme to t e rmate  pregnancy. Studies cmied out 
with anlmals have clearly demonstrated that R-(+)-pulegone is both hepatotoxlc and 
pneumotoxic. Pretreatment studies suggested that PB-mduced cytochrome p-450 catalyzed 
reactive metabohte(s) may be responsible for the toxlcity mediated by R-(+)-pulegone. Our 
earher biochemcal, hght and electron microscopic studies showed that pulegone caused 
necrosis of the h e r .  It has been demonstrated that R-(+)-pulegone is extensively 
metabohzed and metabohc activation of R-(+)-pulegone to reactive metabohtes has been 
shown to be responsible for the observed toxlcity. Two major pathways are involved m the 
metabohsm of R-(+)-pulegone, one of the pathways is mitiated by the regiospeclfic 
hydroxylation to Phydroxypulegone, which further gets transformed to menthofuran. In the 
other major pathway, pulegone undergoes hydroxylation at C-5 posltion which results m the 
formation of piperitenone(3). Most of the metabohtes of R-(+)-pulegone arise either 
from menthofuran or piperitenone. It has been estlrnated earlier that menthofuran is 
responsible for nearly one-half of the toxicity med~ated by R-(+)-pulegone. This observation ~ 
suggests that pulegone ehcits toxicity either dlrectly or through metabolites formed 
I 
independently of menthofuran. The pathway initiated through C-5 hydroxyiation of R-(+)- 
pulegone could also generate metabohtes responsible for part of the toxicity mediated by R- 
(+)-pulegone. In fact the hepatotoxlc potential of piperitenone(3), 4-methyl-2- 
cyclohexenone(7) and p-cresol(9), the major metabolites of R-(+)-pulegone, have not been 
assessed so far. Surprisingly inversion of configuration of the C-5 methyl group markedly 
I 
affects the hepatotoxic potential. Thus S-(-)-pulegone(1) is far less hepatotoxlc than its R- , 
enantiomer, However the reason for the discrepancy m the toxicity mediated by these two 
I 
enantiomers is riot known. The present investigation was htiated to further evaluate the 
I 
mechslusm of R-(+)-pulegone mediated toxicity and to provide a chermcal basis'for the 1 
1 .*a I 
observed drfference m R-(+)-pulegone and S-(-)-pulegone(1) mediated toxicity. 
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Intraperitoneal admistration of a smgle dose of R-(+)-pulegone and S-(-)- 
pulegone(1) separately, resulted m significant decrease m the level of cytochrome p-450, 
amopyrene N-demethylase and glucose-6-phosphatase m the case of R-(+)-pulegone 
treated rats than m S-(-)-pulegone(1) treated rats. There was a significant (15 fold) increase 
m a serum glutamate pyruvate transarmnase (SGPT) levels m the serum of rats treated ulth 
R-(+)-pulegone, whereas there was only a margmal mcrease (0.62 fold) m S-(-)- 
pulegone(1) treated rats, indicatmg that the S-(-)-pulegone(1) is significantly less toxic than 
R-(+)-pulegone. Hepatotoxic effects of S-(-)-pulegone(1) were tune dependent. 
The intraperitoneal adnun~stration of a smgle dose of piperitenone(3) resulted m a 
considerable decrease in liver mcrosomal cytochrome p-450 and glucose-6-phosphatase 
activities, whereas there was no significant change in serum glutamate pyruvate 
transarmnase activities The effect of piperitenone(3) on rat h e r  rmcrosomal cytochrome p- 
450 zn vztro showed significant destruction of cytochrome p-450 and metabohc activation is 
not obhgatory requrrement for this effect. Experlrnents camed out in vzvo and zn vztro 
suggest that piperitenone is a modest hepatotoxin, but can contribute consid'erably to the R- 
(+)-pulegone mediated toxicity since it is one of the major metabolites formed from R-(+)- 
pulegone. Admistration of 4-methyl-2-cyclohexenone(7) and p-cresol(9) caused margmal 
changes m the h e r  microsomal drug-metabolizmg enzymes. p-Cresol(9) can potentiate the 
toxicity mdrrectly by depletmg the glutathione levels. Pretreatment of rats with 
phenobarbital (PB) potentiated the hepatotoxicity of S-(-)-pulegone(l), piperitenone(3) and 
p-cresol(9), suggesting that a PB-mduced cytochrome p-450 catalyzed reactive 
metabohte(s) may be responsible for the hepatotoxlcity caused by S-(-)-puIegone(l), 
piperitenone(3) and p-cresol(9). 
The metabohc fate of S-(-)-pulegone(1) m rats was mvestigated m order to 
understand the mode of biotransformation m mammals. The metabolrtes rsolated and 
characterized fiom the urme of rats dosed with S-(-)-pulegone(1) were (fig. 1): 5- 
hydroxypulegone(2), piperitenone(3), 6,7-dehydromenthofuran(4), S-(-)-menthofuran(5), 4- 
methyl-2-cyclo hexenone(7), p-cresol(9), benzoic acid(l0) piperitone(ll), 7-hydroxy- 
pipentone(l2), isopulegone(l3), pulegol(l4) and 3-methylcyclohexanone(15). These studies 
have shown significant similarities m the mode of biotransformation of S-(-)-pulegone(1) and 
R-(+)-pulegone in the rat system, However, there is a agnificant difference in the relative 
amounts of various major rnetabobtes present in the total urine extracts from R-(+) zmd S+)- 
pulegone(1) treated rats. 
I 
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Urme of rats treated with R-(+)-pulegone contained significantly higher levels of 
plperitenone(3) and p-cresol(9) as compared to then levels m S-(-)-pulegone(1) treated rats, on 
the contrary, the levels of pipentone(l1) and unrnetabolized pulegone were considemlily 
higher in the urine of rats treated with S-(-)-pulegone(1). These o W & n s  were 
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further supported by experiments carried out zn vztro where we have shown that phenobarbital- 
mduced rat liver rmcrosomes convert R-(+)-pulegone to menthofuran and piperitenone(3) at a 
faster rate than thelr formation from S-(-)-pulegone. Some of these findmgs provide a better 
basis for understandmg the difference m the tox~cological effects mediated by these two 
enantiomers. 
Comparative metabohc studies of R-(+)-pulegone and S-(-)-pulegone(1) prompted us 
to Investigate the metabolic fate of piperitenone(3) and 4-methyl-2-cyclohexenone(7) m rats. 
The following urmary metabohtes were isolated and identified by various spectral analyses 
from the urine of the piperitenone treated rats (fig. 2): 6,'t-dehydro- menthofuran(4), p- 
cresol(9), 4-hydroxypiperitenone(17), 5-hydroxypiperitenone(l8), p-mentha-1, 3,5,8- 
tetraen-3-ol(l9), p-mentha-1, 3,5-tnene-3, 8-dio1(20), 7-hydroxypiperitenone(21) and 10- 
hydroxypiperitenone(22). The present study has demonstrated that in case of 
piperitenone(3) both the isopropyhdene methyl groups (C-9 and C-10) are hydroxylated as 
evidenced by the isolation of 10-hydroxypiperitenone(22) and 6,7-dehydromenthofuran(4, 
fig. 2). The 9-hydroxypiperitenone(16) formed readlly undergoes mtramolecular cyclization 
followed by dehydration to yeld 6,7-dehydromenthofuran(4). Contrary to these 
observations, it was noted that m the case of R- (+)-pulegone as well as S-(-)-pulegone(l), 
only the methyl group syn to the carbonyl group is hydroxylated by the liver mcrosomal 
cytochrome p-450 system The compound 6,7-dehydromenthofuran(4) appears to be 
hitherto not known and since it is structurally similar to menthofuran, can elic~t he toxic 
effects m a manner srmilar to that of menthofuran. The most significant pathway appears to 
be the one that is involved in the formation of p-cresol(9) from piperitenone(3). One can 
envisage the formation of p-cresol(9) fiom 6,7-dehydromenthofuran(4) as shown in fig, 2, 
analogous to the pathway estabhhed earher for the conversion of menthofuran to p-cresol 
via the intermediacy of 4-methyl-2-cyclohexenone. It is quite possible that the metabolites 
such as piperitenone(3), 6,7-dehydrornenthofuran(4) and p-cresol(9) formed via pathway A 
(fig. 2) may also contribute towards the pulegone-mediated toxicity m mammals. Studies 
carried out in vitro w th  piperitenone mdicated hydroxylation of all the five allyhc carbon 
atoms and thus supported the zn vzvo studies 
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The metabohc fate of 4-methyl-2-cyclohexenone(7) has been studied in vivo. 
Followrng rnetabohtes were identified fiom rat urine: p-cresol(9) and two diastereomera of 
4-methyl-l,2,3-cyclohexanetrioL We have demonstrated the conversion of 4- 
cyclohexenone(7) to the toxin, p-cresol(9) In v i v a  Thls conversion involvq 
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at C-4 position with the formation of 4-hydroxy-4-methyl-2-cyclohexenone. It was of 
mterest to find out the stereochemistry mvolved m the allylic hydroxylation at C-4 m 4- 
methyl-2-cyclohexenone(7) this hydroxylation apparently leads to the formation of dlfferent 
levels of p-cresol(9) from two enantiomers of pulegone smce 4-methyl-2-cyclohexenone(7) 
formed from both the enantiomers have methyl group at C-4 with different 
stereochemstry. 4-Methyl-2-cyclohexenone(7) was metabolized to 4-hydroxy-4-methyl-2- 
cyclohexenone(8) and p-cresol(9), when mcubated with PB-mduced rat liver mcrosomes. 
The unreacted substrate, 4-methyl-2-cyclohexenone(7), after enzyme reaction mdicated the 
enantiomeric excess suggestmg that one of the enantiomenwas hydroxylated faster than the 
other. This may explam why p-cresol(9) levels are high in the urme of R-(+)-pulegone 
dosed rats than m case of S-(-)-pulegone(1). 
It has been shown earher that R-(+)-pulegone, a monoterpene havmg a- 
isopropylidene ketone group, gets converted to R-(+)-menthofuran, by rat h e r  microsomal 
cytochrome p-450 system m the presence of NADPH and 02. It 1s also known that both R- 
(+)-pulegone and R-(+)-menthofuran co-occur m the same plant. It is interestmg to note that 
m some of the plants, furanoterpenes co-exlst with terpenoids contammg an a- 
isopropylidene ketone unit suggesting the possible biogenetic relationship between these 
two classes of compounds. Plants are known to contam cytochrome p-450 enzyme, but its 
functional role is not fully understood. We wanted to fmd out whether the a-isopropylidene 
ketone unit attached to various terpenoids structurally unrelated to R-(+)-pulegone would be 
accepted by cytochrorne p-450 system as substrates and convert them to the correspondmg 
furanoterpenes analogous to the formation of menthofuran from pulegone. So we have 
synthesized several terpeniods which are either naturally occurring or closely related to 
naturally occurring terpenoids havmg an a-isopropylidene ketone unit. These compounds 
were mcubated with PB-mduced rat liver rnicrosornes in the presence of NADPH and Oz to 
f i d  out whether these model compounds can be transformed i t 0  their correspondmg 
furano terpenes. 
The compounds used m this study were dl-ar-Turmerone, 2- 
isopropylidenecyclohexanone, 4-methyl-2-isopropylldene cyclohexanone, 4,4a,5,6,7,8- 
hexahydro-3-isopropylidene-4a-methyl-8a-hydroxy naphthalen -Zone, 4,4a,5,6,7,8 
Hexahydro-3-kopropyhdene-4a-mthylnaphthlen-2-one, 4,4a,5, 6,7,8 -kxahydfa-3 
isopropylidene- 1,4a-dirnethylnaphthalen-2,5-dio~le, 4,4a,5,6,7,&hexahydroS 
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dene-4a,5-dlrnethyl naphthalen- Zone and mesityl oxide. All these compounds wlth the a- 
isopropylldene ketone unit were shown to get biotransformed to thelr correspondmg furan 
compounds by phenobarbital-induced rat h e r  mcrosomes m the presence of NADPH and 
cytochrome 
C 
p450 
Fig. 3 
The formation of the furan ring was shown to get inhibited by Metyrapone, SKF- 
525A and CO, the cytochrom p-450 mhlbitors. The involvement of cytochrome p-450 m 
the forrnatlon of the furan skeleton was conclusively shown by reconstituting the activity 
usrng purlfied components of the cytochrome p-450 system. DehydroNcmone, a naturally 
o c c m g  eremophdane, was shown to get biotransformed to 4,4a,5,6,7,8-hexahydro-3,4a,5- 
trimethylnap htho(2,3-b)furan (9,lO-dehydrofuranoeremophdane), a furanoeremo- phdane 
which co-exists with dehydrofulunone, and 4,4a,5,6,7,8-hexahydro-3-isopropylidene-4a,5- 
dlrnethyl- 1 1-hydroxy-naphthalen- Zone. The identlficahon of the 4,4a,5,6,7,8-hexahydro- 
3-lsapropylidene-4a,5-dimethyl- 11-hydroxy-naphthalen- 2-one along with the 9,lO- 
dehydrofuranoeremophilane in the assay mixture supports the biosynthetic route proposed 
for the formation of furans. On the basis of our results we have proposed the key step in the 
biosynthesis of furan rmg in lower furanoterpenoids (fig. 3). 
Synopsis of the thesis xm 
In conclusion we have shown that the C-5 hydroxylation pathway involved m the 
metabohsm of pulegone results m the formation of piperitenone(3), 6,7- 
dehydromenthofuran(4), and p-cresol(9). These metabohtes contribute significantly to the 
R-(+)-pulegone mediated toxicity. We have also demonstrated that the S-(-)-pulegone(1) is 
significantly less toxic than R-(+)-pulegone and thu discrepancy may be due to the 
orientation of C-5 methyl group, which plays cruclal role m the metabohsm based toxicity 
by these two enantiomers Stereochemical discrimination by cytochrome p-450 enzyme 
results m the faster rates of metaboltsm of R-(+)-pulegone m preference to S-(-1- 
pulegone(l), thus the level of toxic metabohtes generated vlz, menthofuran, p-cresol(9) and 
piperitenone(3) are more m the R-(+)-pulegone treated anlrnals, wh~ch consequently reflects 
m lugher toxicity than its enantiomer, S -(-)-pulegone(1) These o bservat~ons were further 
supported by studies carried out zn vztro where we have demonstrated that R-enantiorner of 
pulegone is accepted more readlly as substrate than the S-enantiomer. 
We have estabhshed the mechanism by which the P-methyl substituted furans are 
formed fiom terpenoids contmmg an a-isopropyhdene ketone unit, clearly indicatmg the 
biogenetic relationship between these two classes of compounds (fig. 3). Our studies have 
conclusively demonstrated the role of cytochrome p-450 in thls biatransformation These 
results suggest that slrmlar transformation could also take place in the higher plants. The 
rational for the conclusion stems from the fact that there are several mstances where both 
higher plant and rat h e r  microsornal cytochrome p-450 systems have overlappmg substrate 
specificities. 
